ecrin-mdr-crcClinical2012Neoplasm MetastasisLiver MetastasesColorectal CancerColorectal NeoplasmsLiver NeoplasmsNeoplasm MetastasisLiver MetastasesColorectal CancerColorectal NeoplasmsLiver NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2137916China9Objective response rateConversion therapyBevacizumabECRIN MDRNot providedfalseBevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal CancerA multi-center, non-random, open study ,to observe efficacy and safety of bevacizumab plus Oxaliplatin based multidrug chemotherapy as conversion therapy for patients with previously untreated unresectable liver metastases from colorectal cancer.2012-09-152137916NCT01763450